Author Wirths, Oliver

1 to 20 of 71 Items
  • 2024 Journal Article
    ​ ​Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer’s disease​
    Morgado, B.; Klafki, H.-W.; Bauer, C.; Waniek, K.; Esselmann, H.; Wirths, O. & Hansen, N. et al.​ (2024) 
    European Archives of Psychiatry and Clinical Neuroscience,.​ DOI: https://doi.org/10.1007/s00406-023-01751-2 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​A novel interface between the N-terminal and coiled-coil domain of STAT1 functions in an auto-inhibitory manner​
    Remling, L.; Gregus, A.; Wirths, O.; Meyer, T. & Staab, J. F. ​ (2023) 
    Cell Communication and Signaling21(1) art. 170​.​ DOI: https://doi.org/10.1186/s12964-023-01124-1 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model​
    Stazi, M.; Zampar, S.; Klafki, H.-W.; Meyer, T. & Wirths, O.​ (2023) 
    International Journal of Molecular Sciences24(3).​ DOI: https://doi.org/10.3390/ijms24032155 
    Details  DOI 
  • 2023 Journal Article
    ​ ​Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS​
    Liepold, T.; Klafki, H.-W.; Kumar, S.; Walter, J.; Wirths, O.; Wiltfang, J. & Jahn, O.​ (2023) 
    Journal of the American Society for Mass Spectrometry, art. jasms.2c00270​.​ DOI: https://doi.org/10.1021/jasms.2c00270 
    Details  DOI 
  • 2023 Journal Article | 
    ​ ​Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice​
    Bader, A. S.; Gnädig, M.-U.; Fricke, M.; Büschgens, L.; Berger, L. J.; Weggen, S. & Klafki, H.-W. et al.​ (2023) 
    Life13(4) pp. 1053​.​ DOI: https://doi.org/10.3390/life13041053 
    Details  DOI 
  • 2023 Journal Article
    ​ ​Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40​
    Klafki, H.-W.; Wirths, O.; Jahn, O.; Morgado, B.; Esselmann, H. & Wiltfang, J.​ (2023) 
    Clinical Chemistry and Laboratory Medicine,.​ DOI: https://doi.org/10.1515/cclm-2023-0990 
    Details  DOI 
  • 2023 Preprint
    ​ ​Oligodendrocytes and neurons contribute to amyloid-β deposition in Alzheimer’s disease​
    Sasmita, A. O.; Depp, C.; Nazarenko, T.; Sun, T.; Siems, S. B.; Yu, X.& Boehler, C. et al.​ (2023). DOI: https://doi.org/10.1101/2023.12.11.570514 
    Details  DOI 
  • 2022 Journal Article | 
    ​ ​Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?​
    Klafki, H.-W.; Morgado, B.; Wirths, O.; Jahn, O.; Bauer, C.; Esselmann, H. & Schuchhardt, J. et al.​ (2022) 
    Fluids and Barriers of the CNS19(1) art. 96​.​ DOI: https://doi.org/10.1186/s12987-022-00390-4 
    Details  DOI 
  • 2022 Journal Article | Research Paper
    ​ ​An inhibitory effect on the nuclear accumulation of phospho-STAT1 by its unphosphorylated form​
    Menon, P. R.; Staab, J.; Gregus, A.; Wirths, O. & Meyer, T.​ (2022) 
    Cell Communication and Signaling20(1) art. 42​.​ DOI: https://doi.org/10.1186/s12964-022-00841-3 
    Details  DOI 
  • 2022 Journal Article | 
    ​ ​Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice​
    Stazi, M.; Zampar, S.; Nadolny, M.; Büschgens, L.; Meyer, T. & Wirths, O.​ (2022) 
    European Archives of Psychiatry and Clinical Neuroscience,.​ DOI: https://doi.org/10.1007/s00406-022-01431-7 
    Details  DOI 
  • 2021 Journal Article | 
    ​ ​Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis​
    Stazi, M.; Lehmann, S.; Sakib, M. S.; Pena-Centeno, T.; Büschgens, L.; Fischer, A. & Weggen, S. et al.​ (2021) 
    Cellular and Molecular Life Sciences79(1) art. 55​.​ DOI: https://doi.org/10.1007/s00018-021-04062-8 
    Details  DOI 
  • 2021 Journal Article | Research Paper | 
    ​ ​Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease​
    Aichholzer, F.; Klafki, H.-W.; Ogorek, I.; Vogelgsang, J.; Wiltfang, J.; Scherbaum, N. & Weggen, S. et al.​ (2021) 
    Alzheimer's Research & Therapy13(1) art. 94​.​ DOI: https://doi.org/10.1186/s13195-021-00828-1 
    Details  DOI 
  • 2016 Journal Article
    ​ ​Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease​
    Weissmann, R.; Huettenrauch, M.; Kacprowski, T.; Bouter, Y.; Pradier, L.; Bayer, T. A. & Kuss, A. W. et al.​ (2016) 
    Journal of Alzheimer s Disease50(2) pp. 397​-409​.​ DOI: https://doi.org/10.3233/JAD-150745 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ ​N-Truncated A beta(2-X) Starting with Position Two in Sporadic Alzheimer's Disease Cases and Two Alzheimer Mouse Models​
    Savastano, A.; Klafki, H.; Haussman, U.; Oberstein, T. J.; Mueller, P.; Wirths, O. & Wiltfang, J. et al.​ (2016) 
    Journal of Alzheimer s Disease49(1) pp. 101​-110​.​ DOI: https://doi.org/10.3233/JAD-150394 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​I716F AβPP Mutation Associates with the Deposition of Oligomeric Pyroglutamate Amyloid-β and α-Synucleinopathy with Lewy Bodies​
    Sieczkowski, E.; Milenkovic, I.; Venkataramani, V.; Giera, R.; Ströbel, T.; Höftberger, R. & Liberski, P. P. et al.​ (2015) 
    Journal of Alzheimer's Disease44(1) pp. 103​-114​.​ DOI: https://doi.org/10.3233/JAD-141524 
    Details  DOI 
  • 2015 Journal Article
    ​ ​Gene Dosage Dependent Aggravation of the Neurological Phenotype in the 5XFAD Mouse Model of Alzheimer's Disease​
    Richard, B. C. ; Kurdakova, A.; Baches, S.; Bayer, T. A.; Weggen, S. & Wirths, O.​ (2015) 
    Journal of Alzheimer s Disease45(4) pp. 1223​-1236​.​ DOI: https://doi.org/10.3233/JAD-143120 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article | 
    ​ ​Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing​
    Bouter, Y.; Kacprowski, T.; Weissmann, R.; Dietrich, K.; Borgers, H.; Brauss, A. & Sperling, C. et al.​ (2014) 
    Frontiers in Aging Neuroscience6.​ DOI: https://doi.org/10.3389/fnagi.2014.00075 
    Details  DOI  WoS 
  • 2014 Review | 
    ​ ​Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease​
    Bayer, T. A.& Wirths, O.​ (2014)
    Acta Neuropathologica, 127​(6) pp. 787​-801​.​
    Springer. DOI: https://doi.org/10.1007/s00401-014-1287-x 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article
    ​ ​A beta(38) in the Brains of Patients with Sporadic and Familial Alzheimer's Disease and Transgenic Mouse Models​
    Reinert, J.; Martens, H.; Huettenrauch, M.; Kolbow, T.; Lannfelt, L.; Ingelsson, M. & Paetau, A. et al.​ (2014) 
    Journal of Alzheimer s Disease39(4) pp. 871​-881​.​ DOI: https://doi.org/10.3233/JAD-131373 
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article | 
    ​ ​Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal A beta accumulation​
    Christensen, D. Z.; Huettenrauch, M. ; Mitkovski, M.; Pradier, L. & Wirths, O.​ (2014) 
    Frontiers in Aging Neuroscience6 art. 139​.​ DOI: https://doi.org/10.3389/fnagi.2014.00139 
    Details  DOI  PMID  PMC  WoS 

Researcher

Sort

issue date

ASC DESC

Items per Page